Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors.

Documenti analoghi

• Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors.
  di: Condra, J H, et al.
  Pubblicazione: (1992)
• Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors.
  di: Byrnes, V W, et al.
  Pubblicazione: (1993)
• A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
  di: Goldman, M E, et al.
  Pubblicazione: (1993)
• Effects of Amino Acid Substitutions at Position 115 on the Fidelity of Human Immunodeficiency Virus Type 1 Reverse Transcriptase
  di: Boyer, Paul L., et al.
  Pubblicazione: (2000)
• Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.
  di: Nunberg, J H, et al.
  Pubblicazione: (1991)